Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ADHD symptoms or diagnosis at 5 years of age, according to a Norwegian registry-based study.
The findings, which were published in JAMA Network Open, were “reassuring for pregnant women in need of triptans and their health care providers,” Gerd Marie Harris, MScPharm, a doctoral research fellow at the University of Oslo in Norway, told Healio.
“There is limited knowledge about potential long-term consequences for the child after maternal triptan use in pregnancy, and